Tower Research Capital LLC (TRC) GTBP — GT BIOPHARMA INC

Ownership history in Tower Research Capital LLC (TRC)  ·  11 quarters on record

AI Ownership Summary

Tower Research Capital LLC (TRC) reported GT BIOPHARMA INC (GTBP) in 11 quarterly 13F filings from 2024 Q2 through 2026 Q3. The latest visible filing shows GTBP at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this GTBP ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Tower Research Capital LLC (TRC)'s position in GT BIOPHARMA INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

GTBP was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Tower Research Capital LLC (TRC) held GTBP — position size vs. price
% of Fund (quarterly)    GTBP price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 REDUCED — — — 361 -1,335 -78.7% 0.00% $2K 2026-11-16 $3.54
2026 Q2 REDUCED — — — 1,696 -2 -0.1% 0.00% $831 2026-08-11 $7.82
2026 Q1 REDUCED — — — 1,698 -3 -0.2% 0.00% $693 2026-05-15 (Est.) $9.85
2025 Q4 REDUCED — — — 1,701 -3 -0.2% 0.00% $1K 2026-02-17 $11.43
2025 Q3 ADDED — — — 1,704 +1,254 +278.7% 0.00% $999 2025-11-14 $0.92
2025 Q2 REDUCED 51.0% -83.8% ✅ 450 -468 -51.0% 0.00% $2K 2025-08-15 $1.34
2025 Q1 REDUCED 68.5% +66.5% ❌ 918 -1,999 -68.5% 0.00% $2K 2025-05-15 $2.24
2024 Q4 ADDED — — — 2,917 +1,274 +77.5% 0.00% $9K 2025-02-13 $2.24
2024 Q3 REDUCED 24.4% +32.0% ❌ 1,643 -530 -24.4% 0.00% $4K 2024-11-14 $3.01
2024 Q2 REDUCED 5.6% -18.4% ✅ 2,173 -128 -5.6% 0.00% $6K 2024-08-13 $2.41
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Tower Research Capital LLC (TRC) and GTBP

These are the practical questions this page is built to answer before you even open the full history table.

How long has Tower Research Capital LLC (TRC) reported owning GTBP?

Tower Research Capital LLC (TRC) reported GTBP across 10 quarterly 13F filings, from 2024 Q2 through 2026 Q3.

What was the largest reported GTBP position in Tower Research Capital LLC (TRC)'s portfolio?

The largest reported portfolio weight for GTBP was 0.00% in 2024 Q4.

What is the latest reported GTBP position on this page?

The most recent filing on this page is 2026 Q3, when Tower Research Capital LLC (TRC) reported 361 shares, equal to 0.00% of portfolio, with an estimated market value of $2K.

What does the chart on this GTBP ownership page compare?

The chart compares Tower Research Capital LLC (TRC)'s quarterly GTBP portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Tower Research Capital LLC (TRC) time their GTBP position?

Based on 13F filing dates vs. subsequent GTBP price moves, Tower Research Capital LLC (TRC) correctly timed 7 out of 10 reported position changes (70%). The annualised alpha on GTBP relative to SPY over the holding period was -8.3%.

← Back to Tower Research Capital LLC (TRC) Holdings